의료 분야 에지 컴퓨팅 시장 : 도입 형태, 최종사용자, 컴포넌트, 용도별 예측(2026-2032년)

The Edge Computing in Healthcare Market was valued at USD 7.79 billion in 2025 and is projected to grow to USD 9.61 billion in 2026, with a CAGR of 25.23%, reaching USD 37.65 billion by 2032.

A strategic orientation to edge computing in healthcare that highlights operational advantages, clinical use cases, and governance prerequisites for adoption

Edge computing is reshaping how healthcare organizations collect, process, and act upon clinical and operational data by relocating compute resources closer to the points of care. This shift reduces latency for critical decision-making, limits the volume of data that must traverse congested networks, and helps organizations meet privacy and compliance objectives by keeping sensitive information within defined boundaries. As distributed medical devices, imaging modalities, and continuous monitoring systems proliferate, on-site edge processing enables real-time analytics and intervention where milliseconds can affect outcomes.

Healthcare leaders should view edge computing as an enabling architecture rather than a single product; it integrates hardware, software, orchestration, and managed services into cohesive solutions that can augment clinical workflows and support emerging applications such as AI-assisted diagnostics and remote procedure support. Importantly, deploying edge capabilities requires deliberate attention to interoperability, data governance, and clinician experience so that the technology enhances rather than disrupts care pathways. In subsequent sections, the report explores the strategic and operational levers that influence successful adoption, including deployment models, end-user priorities, and the broader ecosystem dynamics that will determine which implementations are sustainable and high value over time.

An analysis of converging technological, regulatory, and care delivery trends that are accelerating edge computing from pilot projects to strategic healthcare infrastructure

The healthcare landscape is undergoing transformative shifts driven by several converging forces that amplify the relevance of edge computing. First, advances in on-device compute and efficient AI models are enabling sophisticated inference at the network edge, moving diagnostic and monitoring intelligence closer to patients and care teams. Second, the rise of continuous remote monitoring and immersive telehealth interactions has increased demand for predictable network performance and low-latency processing, making centralized cloud-only architectures less optimal for many clinical tasks.

Concurrently, regulatory emphasis on data protection and local residency is prompting architectures that minimize unnecessary data movement, while payers and providers are experimenting with value-based models that reward demonstrable improvements in clinical outcomes and operational efficiency. Supply chain dynamics and component innovation are shifting vendor strategies toward modular, interoperable platforms that support hybrid deployment patterns. Taken together, these trends are creating an environment in which edge computing moves from pilot projects to strategic infrastructure, with the potential to reconfigure care delivery models and vendor relationships across the health ecosystem.

How evolving tariff dynamics and supply chain responses are reshaping procurement strategies and deployment resilience for healthcare edge computing implementations

Policy shifts that affect tariffs and cross-border trade can materially influence the supply chain economics and sourcing strategies for hardware-intensive edge deployments. In environments where increased tariffs raise the landed cost of compute nodes, networking equipment, and specialized imaging hardware, procurement teams respond by reassessing supplier geography, negotiating longer-term fixed-price agreements, and prioritizing modular architectures that reduce vendor lock-in. Consequently, procurement cycles may lengthen as capital decisions are paired with risk mitigation plans to address potential cost volatility.

Tariff-driven cost pressure also tends to accelerate nearshoring and diversification strategies among hardware manufacturers and integrators, prompting them to cultivate alternative production footprints and local assembly capabilities. For healthcare organizations, this trend can produce both friction and opportunity: while short-term component availability and price adjustments may complicate rollout schedules, a more distributed supplier base can improve long-term resilience and shorten lead times for critical equipment. It is important for clinical and IT leaders to incorporate scenario planning for tariff-induced supply chain changes into procurement and rollout strategies, to preserve program momentum while protecting budgets and clinical continuity.

A nuanced segmentation framework linking deployment modes, end-user priorities, component stacks, and applications to illuminate differentiated value paths for edge solutions

Understanding the market requires granular segmentation across how solutions are deployed, who uses them, what components compose them, and the specific clinical and operational applications they enable. Deployment mode differentiates between cloud hybrid environments and strictly on-premise installations. Within hybrid approaches, configurations range from integrated hybrid stacks to private cloud and public cloud extensions that distribute workloads, while on-premise options focus on localized compute resources placed either in edge data centers or within enterprise data center footprints. These distinctions matter because they influence latency characteristics, governance boundaries, and the operational model for updates and maintenance.

End-user segmentation reveals distinct priorities among academic research institutes, diagnostic laboratories, emergency medical services, and hospitals and clinics. Academic research institutes encompass both research centers and universities that prioritize data-rich experimentation and high-performance compute, whereas diagnostic laboratories break down into pathology labs and radiology centers that emphasize throughput and image processing. Emergency medical services span ambulance services and emergency response centers where ruggedized, low-latency solutions are essential. Hospitals and clinics include government hospitals, private hospitals, and specialty clinics, each with differing procurement processes, regulatory constraints, and care models.

Component-level segmentation separates hardware, services, and software into complementary layers. Hardware consists of compute devices, network devices, and storage devices that determine performance envelopes. Services include managed services, professional services, and support maintenance that define the operational support model. Software covers edge analytics, management orchestration, and security surveillance, which collectively enable local intelligence, lifecycle management, and protection against evolving threats. Finally, application segmentation ties the technical stack to clinical value: clinical decision support systems provide diagnostic support and treatment recommendations; hospital asset management encompasses equipment maintenance and inventory tracking; medical imaging diagnostics focuses on AI-powered imaging and real-time image processing; remote patient monitoring is divided among ambient, implantable, and wearable monitoring modalities; and telemedicine teleconsultation spans remote surgery assistance and video consultation. These layered segmentations create a matrix of requirements and value propositions that vendors and health systems must map when prioritizing investments and pilots.

Regional variations in regulatory regimes, procurement behavior, and infrastructure readiness that determine differentiated adoption trajectories across global healthcare markets

Regional dynamics substantially shape how edge computing is adopted and scaled across healthcare systems, with distinct regulatory, economic, and infrastructure conditions in the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, strong private-sector investment, a robust medical device ecosystem, and large integrated health systems create fertile ground for early deployments that emphasize interoperability, analytics, and enterprise-grade managed services. However, fragmented reimbursement and procurement processes mean that scalable adoption often depends on demonstrable ROI and alignment with institutional priorities.

In Europe, Middle East & Africa, regulatory frameworks and national healthcare policies exert a pronounced influence on data residency and compliance requirements, which in turn make hybrid and on-premise architectures more attractive in many jurisdictions. National initiatives to modernize health IT combined with nascent local manufacturing capabilities are encouraging regional partnerships and pilot programs. In the Asia-Pacific region, rapid digitization, high patient volumes, and strong government-led modernization programs are driving heterogeneous adoption patterns; some markets emphasize cost-efficient, scalable cloud hybrids while others invest in localized edge infrastructure to support advanced imaging and large-scale remote monitoring initiatives. Across these geographies, local talent availability, supply chain logistics, and public policy priorities will determine which use cases move fastest from experimentation to routine clinical use.

Competitive and partnership strategies among vendors that balance turnkey edge solutions, open platform approaches, and service-led models to meet healthcare needs

Leading companies in the edge computing ecosystem are adopting a range of strategic postures to address healthcare requirements, from vertically integrated offerings to open, standards-based platforms designed for rapid interoperability. Some vendors focus on delivering turnkey appliances optimized for specific clinical workloads such as imaging acceleration or real-time monitoring, while others emphasize modular software layers that enable orchestration across heterogeneous hardware. Strategic partnerships between hardware manufacturers, software providers, systems integrators, and clinical technology specialists are becoming more common as stakeholders seek to bundle capabilities and accelerate time to value.

Service models are also evolving; managed service providers and professional services organizations are positioning to take responsibility for lifecycle management, security hardening, and regulatory compliance so that clinical teams can focus on patient care. At the same time, companies investing in developer ecosystems and open APIs are lowering barriers for third-party innovation, which is critical for scaling diverse use cases. Finally, corporate strategies increasingly reflect a balance between pursuing proprietary differentiation and contributing to interoperability initiatives so that solutions can be adopted across multi-vendor environments and heterogeneous health system architectures.

Actionable guidance for healthcare executives and vendors to prioritize pilots, harden security, align workflows, and structure procurement for scalable edge deployments

Healthcare leaders should pursue a staged, use-case-driven approach to edge adoption that prioritizes initiatives with clear clinical or operational impact, measurable outcomes, and manageable integration complexity. Begin with pilot projects that focus on low-latency, high-value scenarios such as AI-accelerated imaging triage, remote monitoring for high-risk patient cohorts, or operational visibility for critical assets. Design pilots with clear success criteria, defined data governance rules, and a path to scale that includes integration with electronic health records and clinical workflows.

Security and privacy must be foundational: adopt a defense-in-depth strategy that includes device hardening, secure orchestration, encryption in transit and at rest, and robust identity and access controls. Engage clinical stakeholders early to align technology behavior with workflow expectations and reduce friction in adoption. On the procurement side, favor modular contracts and flexible financing models that permit incremental scaling and vendor diversification. Finally, invest in talent development and change management to ensure that IT, biomedical engineering, and clinical operations can jointly support edge ecosystems and translate technical capability into improved patient outcomes.

A rigorous, multi-method research approach combining literature review, stakeholder interviews, case analyses, and validation to derive practical insights for healthcare implementers

The research underpinning this analysis synthesizes multiple evidence streams to produce actionable, validated insights. First, a comprehensive review of technical literature, regulatory documents, and vendor publications provided the foundational landscape and clarified the taxonomy of deployment models, components, and applications. Second, structured interviews with a cross-section of stakeholders-including hospital IT leaders, clinical champions, device manufacturers, systems integrators, and managed service providers-offered practical perspectives on challenges and successful patterns for deployment. Third, comparative case analyses of representative implementations illuminated common success factors and failure modes across clinical domains and geographies.

Qualitative findings were triangulated through vendor capability mapping and implementation pattern analysis, with scenario planning employed to explore implications of supply chain shifts and policy changes. Throughout the research cycle, draft findings were validated through follow-up consultations with domain experts to ensure practical relevance and factual accuracy. Limitations include variability in public disclosure of deployment outcomes and the rapid pace of technological change; therefore, readers are encouraged to treat the study as a strategic guide that should be supplemented with organization-specific feasibility assessments and pilot data.

A concise synthesis of why targeted edge deployments, underpinned by governance and interoperability, are essential for next-generation healthcare delivery

Edge computing represents a pragmatic evolution in healthcare IT architecture that enables faster, localized decision-making while addressing privacy and bandwidth constraints inherent in centralized models. When aligned with clear clinical objectives, robust governance, and interoperable design principles, edge deployments can materially improve responsiveness, diagnostic throughput, and operational efficiency. The transition from exploratory pilots to operationalized infrastructure requires deliberate attention to procurement strategy, talent, security, and vendor relationships so that early wins can be expanded into institution-wide capabilities.

Looking forward, organizations that balance pragmatic, use-case-led pilots with a strategic view of platform interoperability and lifecycle services will be better positioned to capture the benefits of edge computing. The pace of adoption will vary by region and care setting, but the underlying imperative is consistent: embed intelligence where care is delivered, manage risk through rigorous governance, and invest in partnerships that accelerate clinical value realization. This conclusion underscores the need for decision-makers to act with both urgency and discipline in planning next-generation care architectures.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Porter's Five Forces Analysis
• 4.4. PESTLE Analysis
• 4.5. Market Outlook
  • 4.5.1. Near-Term Market Outlook (0-2 Years)
  • 4.5.2. Medium-Term Market Outlook (3-5 Years)
  • 4.5.3. Long-Term Market Outlook (5-10 Years)
• 4.6. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Edge Computing in Healthcare Market, by Deployment Mode

• 8.1. Cloud Hybrid
  • 8.1.1. Hybrid
  • 8.1.2. Private Cloud
  • 8.1.3. Public Cloud
• 8.2. On Premise

9. Edge Computing in Healthcare Market, by End User

• 9.1. Academic Research Institutes
  • 9.1.1. Research Centers
  • 9.1.2. Universities
• 9.2. Diagnostic Laboratories
  • 9.2.1. Pathology Labs
  • 9.2.2. Radiology Centers
• 9.3. Emergency Medical Services
  • 9.3.1. Ambulance Services
  • 9.3.2. Emergency Response Centers
• 9.4. Hospitals Clinics
  • 9.4.1. Government Hospitals
  • 9.4.2. Private Hospitals
  • 9.4.3. Specialty Clinics

10. Edge Computing in Healthcare Market, by Component

• 10.1. Hardware
  • 10.1.1. Compute Devices
  • 10.1.2. Network Devices
  • 10.1.3. Storage Devices
• 10.2. Services
  • 10.2.1. Managed Services
  • 10.2.2. Professional Services
  • 10.2.3. Support Maintenance
• 10.3. Software
  • 10.3.1. Edge Analytics
  • 10.3.2. Management Orchestration
  • 10.3.3. Security Surveillance

11. Edge Computing in Healthcare Market, by Application

• 11.1. Clinical Decision Support Systems
  • 11.1.1. Diagnostic Support
  • 11.1.2. Treatment Recommendations
• 11.2. Hospital Asset Management
  • 11.2.1. Equipment Maintenance
  • 11.2.2. Inventory Tracking
• 11.3. Medical Imaging Diagnostics
  • 11.3.1. AI Powered Imaging
  • 11.3.2. Real Time Image Processing
• 11.4. Remote Patient Monitoring
  • 11.4.1. Ambient Monitoring
  • 11.4.2. Implantable Monitoring
  • 11.4.3. Wearable Monitoring
• 11.5. Telemedicine Teleconsultation
  • 11.5.1. Remote Surgery Assistance
  • 11.5.2. Video Consultation

12. Edge Computing in Healthcare Market, by Region

• 12.1. Americas
  • 12.1.1. North America
  • 12.1.2. Latin America
• 12.2. Europe, Middle East & Africa
  • 12.2.1. Europe
  • 12.2.2. Middle East
  • 12.2.3. Africa
• 12.3. Asia-Pacific

13. Edge Computing in Healthcare Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Edge Computing in Healthcare Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. United States Edge Computing in Healthcare Market

16. China Edge Computing in Healthcare Market

17. Competitive Landscape

• 17.1. Market Concentration Analysis, 2025
  • 17.1.1. Concentration Ratio (CR)
  • 17.1.2. Herfindahl Hirschman Index (HHI)
• 17.2. Recent Developments & Impact Analysis, 2025
• 17.3. Product Portfolio Analysis, 2025
• 17.4. Benchmarking Analysis, 2025
• 17.5. Abbott Laboratories
• 17.6. Advantech Co., Ltd.
• 17.7. Akamai Technologies, Inc.
• 17.8. Amazon Web Services, Inc.
• 17.9. Cisco Systems, Inc.
• 17.10. Dell Technologies Inc.
• 17.11. GE HealthCare Technologies Inc.
• 17.12. Google LLC
• 17.13. Hewlett Packard Enterprise Company
• 17.14. Intel Corporation
• 17.15. International Business Machines Corporation (IBM)
• 17.16. Johnson & Johnson
• 17.17. Koninklijke Philips N.V.
• 17.18. Medtronic plc
• 17.19. Microsoft Corporation
• 17.20. NVIDIA Corporation
• 17.21. Oracle Corporation
• 17.22. Siemens Healthineers AG
• 17.23. Tempus Labs, Inc.
• 17.24. Viz.ai, Inc.